Petra Eveliina Kukkaro

Title: Petra Eveliina Kukkaro: Innovator in Dengue Virus Research

Introduction

Petra Eveliina Kukkaro is a notable inventor based in Singapore, recognized for her contributions to the field of medical research, particularly in the area of dengue virus treatment. With a total of two patents to her name, Kukkaro has made significant strides in developing therapeutic solutions for dengue virus infections.

Latest Patents

Kukkaro's latest patents focus on human monoclonal antibodies with specificity for dengue virus serotype 1 E protein. These patents detail compositions and methods for the treatment or prevention of dengue virus infection in vertebrate subjects. Specifically, the patents disclose human neutralizing monoclonal antibodies isolated from EBV immortalized B cells derived from patients who have recovered from dengue infection. The methods outlined in these patents provide a framework for administering such antibodies in amounts effective to reduce, eliminate, or prevent relapse from infection.

Career Highlights

Throughout her career, Kukkaro has worked with esteemed institutions such as the National University of Singapore and DSO National Laboratories. Her work in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of Kukkaro's notable coworkers include Paul Macary and Ee Ping Evelyn Teoh, who have also played significant roles in advancing research in their respective areas.

Conclusion

Petra Eveliina Kukkaro's innovative work in the development of treatments for dengue virus infection highlights her commitment to improving public health. Her patents and collaborations reflect her dedication to advancing medical research and finding effective solutions for infectious diseases.